[Risk factors associated with ceftazidime-resistant Klebsiella pneumoniae infection]

Enferm Infecc Microbiol Clin. 2003 Feb;21(2):72-6. doi: 10.1016/s0213-005x(03)72886-9.
[Article in Spanish]

Abstract

Introduction: Risk factors associated with ceftazidime-resistant Klebsiella pneumoniae (CAZ-R Kp) infection may vary among hospitals and in the same hospital at different time points. Knowledge of these factors is required to establish suitable infection control programs.

Methods: A case-control study was conducted to assess risk factors for CAZ-R Kp infection. Thirty-two cases were compared with 28 controls admitted to a 200-bed general hospital during 1999 and 2000.

Results: In the univariate analysis Kp CAZ-R isolates were significantly associated with nosocomial acquisition (OR 5 17.40), prior antibiotic use (OR 5 14.94), particularly ciprofloxacin use (OR 5 5), and hospitalization stay of more than 6 days (OR 5 6.72). Significantly associated variables in the logistic regression analysis included nosocomial acquisition (OR 5 9.29), prior antibiotic use (OR 5 6.21), and particularly, ciprofloxacin use (OR 5 10.84).

Conclusions: Efforts toward more rational overall antibiotic use and particularly ciprofloxacin use, combined with infection control measures are necessary to decrease the prevalence of CAZ-R Kp in our hospital.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Argentina / epidemiology
  • Bacterial Proteins / genetics
  • Case-Control Studies
  • Ceftazidime / pharmacology*
  • Ceftazidime / therapeutic use
  • Cephalosporin Resistance* / genetics
  • Ciprofloxacin / adverse effects
  • Ciprofloxacin / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Disease Susceptibility
  • Drug Resistance, Multiple, Bacterial / genetics
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Immunocompromised Host
  • Infection Control / organization & administration
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / epidemiology*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / genetics
  • Length of Stay / statistics & numerical data
  • Logistic Models
  • Male
  • Middle Aged
  • Risk Factors
  • Superinfection
  • beta-Lactamases / genetics

Substances

  • Bacterial Proteins
  • Ciprofloxacin
  • Ceftazidime
  • beta-Lactamases
  • beta-lactamase CAZ-1